BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31413763)

  • 21. Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis.
    Wang Y; Zhang Y; Pan C; Ma F; Zhang S
    PLoS One; 2015; 10(2):e0118647. PubMed ID: 25706383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
    Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
    PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of interleukin-17 in lung cancer: A systematic review with meta-analysis based on Chinese patients.
    Wang XF; Zhu YT; Wang JJ; Zeng DX; Mu CY; Chen YB; Lei W; Zhu YH; Huang JA
    PLoS One; 2017; 12(9):e0185168. PubMed ID: 28934305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and clinicopathological significance of GPRC5A in various cancers: A systematic review and meta-analysis.
    Dai L; Jin X; Liu Z
    PLoS One; 2021; 16(3):e0249040. PubMed ID: 33788883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic role of microRNA-221 in various human malignant neoplasms: a meta-analysis of 20 related studies.
    Yang J; Zhang JY; Chen J; Xu Y; Song NH; Yin CJ
    PLoS One; 2014; 9(1):e87606. PubMed ID: 24475314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis.
    Zhou L; Dai C; Tian T; Wang M; Lin S; Deng Y; Xu P; Hao Q; Wu Y; Yang T; Zhu W; Dai Z
    J Cancer; 2018; 9(23):4355-4362. PubMed ID: 30519340
    [No Abstract]   [Full Text] [Related]  

  • 27. MicroRNA-10b expression predicts long-term survival in patients with solid tumor.
    Zhang Y; Wang LJ; Yang HQ; Wang R; Wu HJ
    J Cell Physiol; 2019 Feb; 234(2):1248-1256. PubMed ID: 30191959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between miR-200 Family Overexpression and Cancer Prognosis.
    Liu W; Zhang K; Wei P; Hu Y; Peng Y; Fang X; He G; Wu L; Chao M; Wang J
    Dis Markers; 2018; 2018():6071826. PubMed ID: 30069274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Role of MicroRNA-126 for Survival in Malignant Tumors: A Systematic Review and Meta-Analysis.
    Bu J; Li H; Li XY; Liu LH; Sun W; Xiao T
    Dis Markers; 2015; 2015():739469. PubMed ID: 26351404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of MicroRNA-196a in Asian Cancer Patients: a Meta-Analysis.
    Cai X; Liu X; Lu N; Xiao M; Li Z
    Clin Lab; 2016 Nov; 62(11):2257-2265. PubMed ID: 28164681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-92a Family: A Novel Diagnostic Biomarker and Potential Therapeutic Target in Human Cancers.
    Jiang M; Li X; Quan X; Li X; Zhou B
    Front Mol Biosci; 2019; 6():98. PubMed ID: 31632984
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic Value of miR-375 for Survival Outcomes in Various Cancers: A Systematic Review and Meta-Analysis.
    Dan B; Luo J; Li K; Chen S
    Oncol Res Treat; 2018; 41(1-2):47-50. PubMed ID: 29402861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and Clinicopathological Value of
    Liang H; Xiong Z; Li Y; Kong W; Yao Z; Li R; Deng M; Hu K
    Biomed Res Int; 2018; 2018():4621015. PubMed ID: 30079348
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic value and clinicopathologic significance of nm23 in various cancers: A systematic review and meta-analysis.
    Liu L; Li M; Zhang C; Zhang J; Li G; Zhang Z; He X; Fan M
    Int J Surg; 2018 Dec; 60():257-265. PubMed ID: 30389538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic role of microRNA-203 in various carcinomas: evidence from a meta-analysis involving 13 studies.
    Liang Y; Yang W; Zhu Y; Yuan Y
    Springerplus; 2016; 5(1):1538. PubMed ID: 27652111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated miR-21 is associated with poor prognosis in non-small cell lung cancer: a systematic review and meta-analysis.
    Yuan Y; Xu XY; Zheng HG; Hua BJ
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4166-4180. PubMed ID: 30024605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.
    Ye Z; Zhang X; Luo Y; Li S; Huang L; Li Z; Li P; Chen G
    PLoS One; 2016; 11(9):e0163162. PubMed ID: 27657690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis.
    Chen X; Lun L; Hou H; Tian R; Zhang H; Zhang Y
    Cell Physiol Biochem; 2017; 41(4):1424-1434. PubMed ID: 28315877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the prognostic value of miR-148/152 family in cancers: based on a systemic review of observational studies.
    Duan F; Liu W; Fu X; Feng Y; Dai L; Cui S; Yang Z
    Oncotarget; 2017 Sep; 8(44):77999-78010. PubMed ID: 29100442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.